• Bio-Path Holdings created a new class of Series B Preferred stock on July 14, 2026, authorizing 5,000,000 shares.
• Each Series B Preferred share converts into 1,000 common shares, voting on an as-converted basis.
• The Series B Preferred carries no dividends, no liquidation amount above $0.01 par value.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio-Path Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001663577-26-000218), on July 16, 2026, and is solely responsible for the information contained therein.